GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently becoming a prominent focus in therapeutic research, largely due to its notable impact on treating ailments such as second type diabetes and excess body fat. Ongoing trials have demonstrated that in addition to glucose regula